Partnership for Safe Medicines rounds up the cases, a 41-year-old in July and a 49-year-old in September, plus new FDA findings at a Texas compounder.
Recap by typeshit. Full story at Partnership for Safe Medicines.
Both suppliers of compounded semaglutide and tirzepatide ingredients landed on the FDA import-alert list. Times Now also covers dosing mistakes with compounded vials.
Penn researchers stress the self-reports in JAMA Network Open don't prove the drug caused anything, but increased appetite topped the list despite trials pointing to nausea.
The visits came in the country's largest healthcare system, with the trend credited to wellness influencers and young people among those affected.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
Ashlee Rowe studies grasshopper mice that shrug off bark scorpion stings. OU has filed a patent on her redesigned peptides, which are not yet tested.
A short TikTok lists side effects tied to retatrutide, an experimental drug. There is little detail beyond the title.
Loading…